JUBILANT PHARMOVA
Back to Cashflow Statement
|
JUBILANT PHARMOVA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-69 Cr | ₹-40 Cr | ₹425 Cr | ₹-664 Cr | ₹166 Cr |
What is the latest Net Cash Inflow / Outflow ratio of JUBILANT PHARMOVA ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-69 Cr |
Mar2023 | ₹-40 Cr |
Mar2022 | ₹425 Cr |
Mar2021 | ₹-664 Cr |
Mar2020 | ₹166 Cr |
How is Net Cash Inflow / Outflow of JUBILANT PHARMOVA Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-69 Cr | Negative | |
Mar2023 | ₹-40 Cr | Negative | |
Mar2022 | ₹425 Cr | Positive | |
Mar2021 | ₹-664 Cr | Negative | |
Mar2020 | ₹166 Cr | - |
Compare Net Cash Inflow / Outflow of peers of JUBILANT PHARMOVA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JUBILANT PHARMOVA | ₹19,171.0 Cr | 2.4% | 9.1% | 60.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹414,533.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,215.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹120,428.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹116,410.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,253.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
JUBILANT PHARMOVA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JUBILANT PHARMOVA | 2.4% |
9.1% |
60.6% |
SENSEX | -1.4% |
1.8% |
3.3% |
You may also like the below Video Courses